Not Sure about Losing more Brahms? they are commercialising their /our products that costs for staff to travel and stay and negotiate terms for licenses which is revenueing rewards.
Actual income is up 16% across the company including the $800k R and D rebate.. I can see income will quickly surpass our out goings and this company will become profitable if they stay true to the strategy...
I will busting out the Champagne when I hear we have secured another 3 territories under license for the ProMarker D test.
Plus they run this company on an oily rag,, I'm in other Biotechs where the wage bill is $400k a month...
Ann: Annual Report to shareholders, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $187.1K | 634.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 81754 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.57pm 27/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |